CiPe:Care Odense ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  2.9% 2.9% 2.9% 2.9% 2.9%  
Bankruptcy risk  5.1% 4.5% 2.0% 3.1% 1.7%  
Credit score (0-100)  43 45 68 56 74  
Credit rating  BBB BBB A BBB A  
Credit limit (kDKK)  0.0 0.0 1.2 0.0 11.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  10,188 11,097 13,055 12,634 13,875  
EBITDA  1,036 748 1,280 365 873  
EBIT  977 680 1,212 298 823  
Pre-tax profit (PTP)  785.0 1,091.0 1,409.0 153.0 1,182.2  
Net earnings  563.0 917.0 1,118.0 76.0 986.7  
Pre-tax profit without non-rec. items  785 1,091 1,409 153 1,182  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  2.0 1.0 0.0 0.0 1.4  
Shareholders equity total  2,693 3,609 4,727 4,804 5,790  
Interest-bearing liabilities  1,180 1,520 2,239 894 2,013  
Balance sheet total (assets)  10,549 13,557 13,223 12,202 13,021  

Net Debt  998 1,421 2,130 454 1,785  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  10,188 11,097 13,055 12,634 13,875  
Gross profit growth  0.1% 8.9% 17.6% -3.2% 9.8%  
Employees  23 24 27 27 29  
Employee growth %  0.0% 4.3% 12.5% 0.0% 7.4%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  10,549 13,557 13,223 12,202 13,021  
Balance sheet change%  24.7% 28.5% -2.5% -7.7% 6.7%  
Added value  1,036.0 748.0 1,280.0 366.0 873.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -88 -92 -136 -134 -99  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  9.6% 6.1% 9.3% 2.4% 5.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.0% 9.6% 10.9% 1.9% 10.0%  
ROI %  19.6% 25.6% 24.1% 3.8% 18.6%  
ROE %  23.4% 29.1% 26.8% 1.6% 18.6%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  25.5% 26.6% 35.7% 39.4% 44.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  96.3% 190.0% 166.4% 124.4% 204.4%  
Gearing %  43.8% 42.1% 47.4% 18.6% 34.8%  
Net interest  0 0 0 0 0  
Financing costs %  3.4% 4.9% 2.9% 5.5% 5.2%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  0.9 1.0 1.1 1.2 1.3  
Current Ratio  1.3 1.3 1.5 1.6 1.7  
Cash and cash equivalent  182.0 99.0 109.0 440.0 227.7  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  2,163.0 3,020.0 4,145.0 4,475.0 5,197.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  45 31 47 14 30  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  45 31 47 14 30  
EBIT / employee  42 28 45 11 28  
Net earnings / employee  24 38 41 3 34